Why the study?
The study was conducted to examine peripheral artery atherosclerosis characteristics in patients with CAD based on the presence of T2DM and identify factors associated with multifocal atherosclerosis.
Does the presence of type 2 diabetes mellitus increase the severity of peripheral atherosclerosis and vascular stiffness in patients with coronary artery disease?
Does the presence of type 2 diabetes mellitus increase the severity of peripheral atherosclerosis and vascular stiffness in patients with coronary artery disease?
Type 2 diabetes mellitus is associated with more severe multifocal atherosclerosis, increased vascular stiffness, and reduced ankle-brachial index in patients with coronary artery disease.
T2DM-linked multifocal atherosclerosis patterns in CAD need validation; leaves open causal and screening implications pending prospective data.
AIM: To study the features of atherosclerosis of peripheral arteries in patients with coronary artery disease (CAD) depending on the presence of type 2 diabetes mellitus (T2DM) and to identify factors associated with multifocal atherosclerosis. MATERIALS AND METHODS: The study included 140 patients (77 men and 63 women) with CAD (mean age 62.0 (56.0-66.0) years). The first group included 70 people with CAD and T2DM, and the second group included 70 patients with CAD without T2DM. All patients underwent duplex scanning of the carotid and lower limb arteries (LLA). Local vascular stiffness of the common carotid artery (CCA) was assessed by ultrasound scanning. The Peterson elasticity modulus, distensibility and strain of the CCA were determined. The ankle - brachial index (ABI) was measured by the Doppler method. RESULTS AND DISCUSSION: In the group of patients with T2D, there were statistically more patients with atherosclerotic plaques in both carotid arteries and LLA. Also among patients with T2DM the severity of stenosis of carotid arteries and LLA at all levels was significantly greater. Local carotid stiffness was higher in the first group of patients. The proportion of individuals with reduced ABI.
No takes yet. Share an insight, caveat, or question.
Genkel et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: